secwatch.observer — SEC 8-K summary
======================================

Issuer:     NUVASIVE INC (—)
CIK:        0001142596
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001193125-23-029489
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NuVasive to merge with Globus Medical in all-stock deal; each share to get 0.75 GMED shares
--------------------------------------------------------------------------------

- Each NuVasive common share will be exchanged for 0.75 shares of Globus Medical Class A common stock.
- Transaction requires NuVasive and Globus Medical stockholder approvals, HSR antitrust clearance, and other conditions.
- NuVasive will pay a termination fee of $120M (or $75M in certain circumstances) if deal fails under specified conditions.
- Voting agreement: David Paul and Sonali Paul, owning ~70% voting power of Globus Medical, agree to vote in favor.
- NuVasive board approved excise tax gross-up plan for four executives, capped at $4M total.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1142596/000119312523029489/0001193125-23-029489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1142596/000119312523029489/d451550d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-029489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer